home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

How T Cells Can Detect CMV-infected Cells

  March, 5 2001 10:23
your information resource in human molecular genetics
Hide and seek

Virally infected cells are detected and eliminated from the body by CD8+ T cells using a receptor called the TCR (the T cell receptor for antigen). Detection of the virally infected cell relies on specialized proteins like MHC class I that display viral proteins on the surface of infected cells. This 'flags down' the passing killer T cells for the kill, by identifying the infected cell as an appropriate target. Some viruses are extremely clever, however, and attempt to avoid detection through elaborate subterfuges. Cytomegalovirus (CMV), for example, is a virus that disrupts the production of class I to evade being killed by T cells.

In the March issue of Nature Immunology Nature Immunology (Vol. 2, No. 3), Spies and colleagues have discovered how T cells can detect CMV-infected cells even if they have little class I. CD8+ T cells express another receptor, called NKG2D, that binds to a protein called MIC. MIC is not normally found on most cells. However, when CMV infects cells, it causes the cell to make MIC, which is then expressed on the cell surface. The interaction between NKG2D and MIC 'kick starts' the T cell into action by energizing it to destroy the virally infected cell. A promising new direction for viral research will be investigating whether this strategy applies to the detection of all virally infected cells or is specific for the detection of CMV.

A News & Views was written on this paper by Eric Vivier of Marseille, France.

Thomas Spies
Fred Hutchinson Cancer Research Center
Division of Clinical Research
1100 Fairview Avenue N., D1-100
P.O. Box 19024
Seattle, WA 98109-1024
Tel: 206.667.6940
Fax: 206.667.5978
Email: tspies@fhcrc.org

Eric Vivier
INSERM/CNRS de Marseille-Luminy
Case 906
Marseille 13288
Tel: 33-4-912-674-444
Fax: 33-4-912-694-30
Email: vivier@ciml.univ-mrs.fr

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.